Go to the U of M home page


Wednesday, January 25, 2017

University of Minnesota Joins National Partnership Aimed at Expanding Biopharmaceutical Workforce and Industry

U Joins National Partnership Aimed at Expanding Biopharmaceutical Workforce and Industry

The University of Minnesota will join a team of academic institutions, private companies, governmental entities and non-profit organizations across the U.S. as a partner for the newly established National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIMBL, a public-private partnership supported by a $70M investment from the National Institute of Standards and Technology and at least $129M from other participants, aims to transform biopharmaceutical manufacturing in the U.S.

NIIMBL was announced by Secretary Pritzker in December 2016.

"This partnership will open doors to creating and supporting local biotechnology-related businesses," says Vadim J. Gurvich, Ph.D., M.B.A., Associate Director of the Institute for Therapeutics Discovery and Development within the College of Pharmacy.

Gurvich and six other researchers from the College of Science and Engineering, College of Pharmacy, College of Biological Sciences and Medical School will provide leadership for the University's participation within the partnership.

"This could also open doors to new research collaborations for University of Minnesota faculty," Gurvich said. "Working with local companies, we can make a lasting impact right here in our state, to improve health and find new treatments for diseases like cancer and diabetes."

Read More Here: Health Talk

Thursday, January 19, 2017

Dr. Michael Walters is co-PI on University of Minnesota & Mayo Partnership Project

Dr. Michael Walters is co-PI on a $735,990 UMN/Mayo Partnership award for the project, "Precision Medicine Of Aromatase Inhibitors In Post-Menopausal Women With ER+ Breast Cancer." His Mayo collaborator is Dr. Liewei Wang.

Dr. Daniel Harki Mentioned in News Story

Dr. Daniel Harki is mentioned in the Business Wire story, "Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy." 

Welcome Rita Stodolka

Welcome to Rita Stodolka! Rita has joined the Medicinal Chemistry department as the new NIPTE Executive Office and Administrative Specialist.

Friday, January 13, 2017

Dr. Gunda Georg & Dr. Michael Walters Discuss Research in News Articles

Michael Walters, Ph.D., and Gunda Georg, Ph.D., quoted in multiple news articles, discuss turmeric: 

"Turmeric May Not Be a Miracle Spice After All" - Time
"Turmeric May Be Tasty, But It's Not a Cure-All" -  Smithsonian
"Deceptive curcumin offers cautionary tale for chemists" - Nature
"Turmeric May Not Be a Miracle Spice After All" - Health
"Forget what you've heard" Turmeric seems to have zero medicinal properties" - Quartz
"Turmeric Might Not Have Magical Therapeutic Powers After All" - New York Magazine
"The truth about Turmeric, the so-called wonder spice" -CJOB-AM
"Everybody Needs To Stop With This Turmeric Molecule" - Forbes
"Bummer: Turmeric Isn't The Cure-All We All Thought It Was" -Refinery 29

Read the full research article here: http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00975

Tuesday, January 3, 2017

Dr. Carston Wagner Receives NIH Funding

Dr. Carston Wagner is co-investigator on a $1,373,634 NIH award for the project, "Enzymatic Protein Labeling."

Dr. Vadim Gurvich Quoted in News Article

Vadim Gurvich is quoted in the Busines Wire story, "NIPTE is Partner in Newly Announced National Biopharmaceutical Manufacturing Institute."